Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$2.76
-1.61%
Mkt Cap $251.09M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+626.0%
Consensus $20.00 vs current $2.76
NASDAQ·Healthcare·Biotechnology
$2.76
-1.61%
Mkt Cap $251.09M
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$20.00
Range $20.00 – $20.00
+626.0%
Consensus $20.00 vs current $2.76